Ycellbiomedical Becomes the First Korean
PRP Product to Obtain CE MDR Certification
Recently, PRP (Platelet-Rich Plasma) therapy
has gained significant attention in regenerative medicine,
infertility treatment, dermatology, and orthopedics.
As a medical procedure closely associated with medical devices,
PRP treatment requires both proven safety and clinical effectiveness.
To export medical devices to overseas markets,
compliance with international quality standards is essential.
In particular, CE certification in Europe is considered
a key requirement for entry into the global market.
Ycellbiomedical has recently attracted major attention
by becoming the first Korean PRP product to obtain
CE MDR (Medical Device Regulation) certification.
CE MDD vs. CE MDR:
What’s the Difference?
Previously, European CE certification
for medical devices was regulated
under the Medical Device Directive (MDD 93/42/EEC).
However, since 2017, the European Union has implemented
the Medical Device Regulation (MDR 2017/745/EU)
to strengthen medical device safety requirements
and enforce more rigorous quality assessments.
In short, MDR certification requires significantly stricter
and more complex procedures than the former MDD system.
Due to high costs, lengthy review periods, and rigorous quality audits,
many medical device companies in Europe have reportedly withdrawn
or delayed MDR certification applications.
The First and Only in Korea:
Ycellbiomedical PRP
Despite these challenges,
Ycellbiomedical has successfully obtained CE MDR certification
as the first and only Korean PRP product to achieve this milestone.
This accomplishment demonstrates
the product’s safety, quality, and clinical reliability, strengthening
its competitiveness in the global market.
PRP therapy is used in various clinical settings, including:
● Endometrial regeneration for infertility treatment
● Ovarian function improvement
● Recurrent implantation failure
● Orthopedic applications
● Dermatology and aesthetic treatments
● Hair loss treatment
As PRP continues to expand across regenerative medicine,
certification under MDR serves as a critical benchmark of reliability
for both patients and healthcare professionals.
Significance of MDR Certification and Future Outlook
Ycellbiomedical’s CE MDR certification represents more than regulatory approval—
it reflects recognition of global-level quality management capabilities.
Key implications include:
Strict quality control and enhanced safety assurance
Increased clinical credibility
Strong foundation for expansion into global markets
As PRP technology continues to advance and expand
into broader therapeutic areas,
MDR-certified products will serve as a major competitive advantage
in the global healthcare market.
Conclusion
Ycellbiomedical has become the first and only
Korean PRP product to obtain CE MDR certification,
demonstrating excellence in safety, quality, and global competitiveness.
For patients and healthcare professionals considering PRP therapy,
choosing an MDR-certified product ensures
a more reliable and trustworthy treatment environment.
This milestone is expected to accelerate quality-driven innovation
in Korea’s regenerative medicine and infertility treatment markets.
#Ycellbiomedical #StemCells #HighConcentration #PlateletRichPlasma
#PRPSkin #PRPOrthopedics #PRPHairLoss #PRPInfertility
#PRPTube #PRPKit #MDR
Ycellbiomedical Becomes the First Korean
PRP Product to Obtain CE MDR Certification
Recently, PRP (Platelet-Rich Plasma) therapy
has gained significant attention in regenerative medicine,
infertility treatment, dermatology, and orthopedics.
As a medical procedure closely associated with medical devices,
PRP treatment requires both proven safety and clinical effectiveness.
To export medical devices to overseas markets,
compliance with international quality standards is essential.
In particular, CE certification in Europe is considered
a key requirement for entry into the global market.
Ycellbiomedical has recently attracted major attention
by becoming the first Korean PRP product to obtain
CE MDR (Medical Device Regulation) certification.
CE MDD vs. CE MDR:
What’s the Difference?
Previously, European CE certification
for medical devices was regulated
under the Medical Device Directive (MDD 93/42/EEC).
However, since 2017, the European Union has implemented
the Medical Device Regulation (MDR 2017/745/EU)
to strengthen medical device safety requirements
and enforce more rigorous quality assessments.
In short, MDR certification requires significantly stricter
and more complex procedures than the former MDD system.
Due to high costs, lengthy review periods, and rigorous quality audits,
many medical device companies in Europe have reportedly withdrawn
or delayed MDR certification applications.
The First and Only in Korea:
Ycellbiomedical PRP
Despite these challenges,
Ycellbiomedical has successfully obtained CE MDR certification
as the first and only Korean PRP product to achieve this milestone.
This accomplishment demonstrates
the product’s safety, quality, and clinical reliability, strengthening
its competitiveness in the global market.
PRP therapy is used in various clinical settings, including:
● Endometrial regeneration for infertility treatment
● Ovarian function improvement
● Recurrent implantation failure
● Orthopedic applications
● Dermatology and aesthetic treatments
● Hair loss treatment
As PRP continues to expand across regenerative medicine,
certification under MDR serves as a critical benchmark of reliability
for both patients and healthcare professionals.
Significance of MDR Certification and Future Outlook
Ycellbiomedical’s CE MDR certification represents more than regulatory approval—
it reflects recognition of global-level quality management capabilities.
Key implications include:
Strict quality control and enhanced safety assurance
Increased clinical credibility
Strong foundation for expansion into global markets
As PRP technology continues to advance and expand
into broader therapeutic areas,
MDR-certified products will serve as a major competitive advantage
in the global healthcare market.
Conclusion
Ycellbiomedical has become the first and only
Korean PRP product to obtain CE MDR certification,
demonstrating excellence in safety, quality, and global competitiveness.
For patients and healthcare professionals considering PRP therapy,
choosing an MDR-certified product ensures
a more reliable and trustworthy treatment environment.
This milestone is expected to accelerate quality-driven innovation
in Korea’s regenerative medicine and infertility treatment markets.
#Ycellbiomedical #StemCells #HighConcentration #PlateletRichPlasma
#PRPSkin #PRPOrthopedics #PRPHairLoss #PRPInfertility
#PRPTube #PRPKit #MDR